Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer https://t.co/khjkxq52B2 https://t.co/d7xouQ3DRG
114 followers
257 followers
Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer https://t.co/LJNAYvCMjy
906 followers
New article: Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer https://t.co/QMq8wihNlE #pancreaticcancer #oncology https://t.co/sw8xBI7kzl
353 followers
Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer https://t.co/8B8AnZRogY